Evidence map›Paper›PMID 30397187›Full record

ArticleJournal of lipid research2019

Hepatic VLDL secretion: DGAT1 determines particle size but not particle number, which can be supported entirely by DGAT2.

Zehra Irshad, Nikola Chmel, Raghu Adya, Victor A Zammit

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Molecular Regulation and Therapeutic Targeting of VLDL Production in Cardiometabolic Disease.Cellular and molecular gastroenterology and hepatology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Intracellular Cholesterol Trafficking.Cold Spring Harbor perspectives in biology · 2023
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Zehra IrshadTranslational and Experimental Medicine, Warwick Medical School, Coventry CV4 7AL, United Kingdom.
Nikola ChmelDepartment of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom.
Raghu AdyaTranslational and Experimental Medicine, Warwick Medical School, Coventry CV4 7AL, United Kingdom.
Victor A ZammitTranslational and Experimental Medicine, Warwick Medical School, Coventry CV4 7AL, United Kingdom v.a.zammit@warwick.ac.uk.
University of Warwick · GB

Funding

British Heart Foundation PG/08/087/25872Medical Research Council MC_PC_17136Medical Research Council MR/K012819/1
6 · The paper itself

Abstract

We investigated whether, in view of its activity being expressed on both aspects of the endoplasmic reticulum (ER; dual membrane topology), diacylglycerol acyltransferase 1 (DGAT1) plays a distinctive role in determining the triglyceride (TAG) content of VLDL particles secreted by the liver. Mice in which the DGAT1 gene was specifically ablated in hepatocytes (DGAT1-LKO mice) had the same number of VLDL particles (apoB concentration) in the plasma 1 h after Triton 1339 treatment, but these particles were approximately half the size of VLDL particles secreted by control mice and had a proportionately decreased content of TAG, with normal cholesterol and cholesteryl ester contents. Analyses of purified microsomal fractions prepared from 16 h fasted control and DAGT1-LKO mice showed that the TAG/protein ratio in the ER was significantly lower in the latter. Electron micrographs of these livers showed that those from DGAT1-LKO mice did not show the increased lipid content of the smooth ER shown by control livers. The effects of DGAT1- and DGAT2-specific inhibitors on apoB secretion by HepG2 cells showed that DGAT1 is not indispensable for apoB secretion and demonstrated redundancy in the ability of the two enzymes to support apoB secretion. Therefore, our findings show that DGAT1 is essential for the complete lipidation and maturation of VLDL particles within the lumen of the ER, consistent with its dual topology within the ER membrane. In the mouse, DGAT2 can support apoB secretion (particle number) even when TAG availability for full VLDL lipidation is restricted in the absence of DGAT1.

Indexed as

Particle SizeAnimalsApolipoproteins BDiacylglycerol O-AcyltransferaseEndoplasmic ReticulumGene Expression Regulation, EnzymologicGene Knockout TechniquesHepatocytesHep G2 CellsHumansLipogenesisLipoproteins, VLDLLiverMiceRNA, MessengerApolipoproteins BDgat1 protein, mouseDGAT2 protein, mouseDiacylglycerol O-AcyltransferaseLipoproteins, VLDLRNA, Messengercardiovascular diseasediacylglycerol acyltransferase 1lipids and cholesterollipoproteinsliver metabolismmetabolic syndromemetabolismtriglyceridesvery low density lipoprotein

Identifiers

PMID30397187
PMCPMC6314258
OpenAlexW2899830289

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.